VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease …
VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease …
In a new investigational study of VYTORIN ® (ezetimibe/simvastatin), the cholesterol-lowering medicine from Merck (known as MSD outside the US and Canada), VYTORIN 10/20 mg reduced the incidence of first major vascular events — defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure — by a highly statistically significant 16.1 percent compared to placebo …
Read more on Finanzen.net
Categories: Breast Cancer Doctors Tags: chronic, Disease, Events, ezetimibe/simvastatin, kidney, major, Patients, Reduced, significantly, Vascular, VYTORIN®
PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA
PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA
Clinical Data, Inc., today announced that results of studies using its FAMILION® genetic testing were presented at the 2010 American Heart Association (AHA) meeting. PGxHealth, a division of Clinical Data, together with its collaborators, presented results from the largest, most comprehensive studies of genetic variation associated with certain cardiac conditions that were revealed using …
Read more on News-Medical-Net
Categories: Breast Cancer Doctors Tags: 2010, FAMILION, From, Genetic, PGxHealth, presents, Results, Studies, testing, Using
Oncologists join Mercy
Oncologists join Mercy
Mercy says its addition of 11 oncologists makes it western and central Oklahoma’s largest providers of cancer specialists
Read more on The Oklahoman
Categories: Breast Cancer Doctors Tags: 'mercy, Join, Oncologists
Awareness of COPD Growing, But More Lung Testing Urged
Awareness of COPD Growing, But More Lung Testing Urged
U.S. survey found 69% now know about chronic obstructive pulmonary disease.
Read more on HealthCentral
Tool helps detect who should get chemo
Tool helps detect who should get chemo
MONTREAL, Nov. 10 (UPI) — Canadian researchers say they developed a tool that identifies biomarkers that can predict low-risk breast cancer tumors indicating no need for chemotherapy.
Read more on UPI